Search

Your search keyword '"Liu, Zhefeng"' showing total 183 results

Search Constraints

Start Over You searched for: Author "Liu, Zhefeng" Remove constraint Author: "Liu, Zhefeng"
183 results on '"Liu, Zhefeng"'

Search Results

1. Expert consensus on the diagnosis and treatment of solid tumors with BRAF mutations

5. Central nervous system efficacy of rezivertinib (BPI-7711) in advanced NSCLC patients with EGFR T790M mutation: A pooled analysis of two clinical studies

8. Efficacy and Safety of Rezivertinib (BPI-7711) in Patients With Locally Advanced or Metastatic/Recurrent EGFR T790M-Mutated NSCLC: A Phase 2b Study

15. Expert Consensus on the Diagnosis and Treatment of NRG1/2 Gene Fusion Solid Tumors

18. Research on the Effect of Aerodynamic Imbalance on Fatigue Performance of a Wind Turbine Foundation with Embedded Steel Ring.

19. Clinical definition of secondary resistance to immunotherapy in non‐small cell lung cancer

20. Expert consensus on the diagnosis and treatment of RET gene fusion non‐small cell lung cancer in China

22. International expert consensus on diagnosis and treatment of lung cancer complicated by chronic obstructive pulmonary disease

23. Chinese expert consensus on the diagnosis and treatment of malignant pleural mesothelioma

24. Chinese expert consensus on the diagnosis and treatment of thymic epithelial tumors

30. Central Nervous System Efficacy of Rezivertinib (BPI-7711) in Advanced NCLC Patients with EGFR T790m Mutation: A Pooled Analysis of Two Clinical Trials

31. Effect of mould baffle technology on stray grain formation in single crystal blades by integral fabrication based on 3D printing

32. Chinese expert consensus on the diagnosis and treatment of HER2 ‐altered non–small cell lung cancer

35. Expert consensus on the diagnosis and treatment of NTRK gene fusion solid tumors in China

44. Efficacy and Safety of Rezivertinib (BPI-7711) in Patients with Locally Advanced or Metastatic/Recurrent EGFR T790M Mutated NSCLC: A Phase IIb Study

47. Response Efficacy of PD-1 and PD-L1 Inhibitors in Clinical Trials: A Systematic Review and Meta-Analysis

48. Prognostic value of baseline and change in neutrophil-to-lymphocyte ratio for survival in advanced non-small cell lung cancer patients with poor performance status receiving PD-1 inhibitors

50. The Synergistic Effect of PARP Inhibitors and Immune Checkpoint Inhibitors

Catalog

Books, media, physical & digital resources